How many insider trades does FilingIQ track for CDTX?

FilingIQ tracks 306 Form 4 insider transactions for CDTX (Cidara Therapeutics, Inc.), covering filings from Feb 7, 2010 onwards. 0 of those were filed in the last 90 days.

Are CDTX insiders net buyers or net sellers?

Across the full Form 4 history for CDTX, 36 transactions (12%) were open-market purchases and 42 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does CDTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is CDTX in?

Cidara Therapeutics, Inc. (CDTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.96B.

CDTX insider trading

NasdaqCM Healthcare

Cidara Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

306

Last 90 days

Buys / sells

12% / 14%

Market cap

$6.96B

About Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Company website: www.cidara.com

CDTX insider activity at a glance

FilingIQ has scored 306 insider transactions for CDTX since Feb 7, 2010. The most recent filing in our index is dated Jan 7, 2026.

Across the full history, 36 open-market purchases and 42 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CDTX insider trades is 58.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live CDTX trades on FilingIQ Raw filings on SEC EDGAR

Latest CDTX Form 4 filings

Stein Jeffrey President & CEO

P Jun 7, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for CDTX?: FilingIQ tracks 306 Form 4 insider transactions for CDTX (Cidara Therapeutics, Inc.), covering filings from Feb 7, 2010 onwards. 0 of those were filed in the last 90 days.
Are CDTX insiders net buyers or net sellers?: Across the full Form 4 history for CDTX, 36 transactions (12%) were open-market purchases and 42 (14%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CDTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is CDTX in?: Cidara Therapeutics, Inc. (CDTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $6.96B.

Methodology & sources

Every CDTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.